Ashar Bhavesh's Form 4 filing
SpringWorks Therapeutics, Inc.SWTX · filed Feb 5, 2024
- Accession no.
- 0001104659-24-010827
- Filed
- Feb 5, 2024
- Trade date
- Feb 2-5, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $381.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ashar BhaveshCIK 0001849740 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Common Stock | SSaleDisposed | −1,089 | $43.75F2 | −$47,643.75 | 65,121 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −1,667 | $44.31F3 | −$73,864.77 | 63,454 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −378 | $46.00F4 | −$17,388 | 63,076 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −88 | $46.37F5 | −$4,080.56 | 62,988 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −4,834 | $49.32F6 | −$238,412.88 | 58,154 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $44.035. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.05 to $44.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.29 to $46.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.29 to $47.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.